From: Cell adhesion and intracellular calcium signaling in neurons
CAMs | Method/Ca2+indicator | Ligand, concentration | Cell types (localization) | Effect on Ca2+ | Inhibitors tested (effect on ligand induced Ca2+increase) | References |
---|---|---|---|---|---|---|
IgSF | Â | Â | Â | Â | Â | Â |
NCAM | Fluorimetry/Quin-2AM | Polyclonal NCAM antibodies, 0.4-1 mg/ml | PC12 cells | ↑ | Verapamil (full inhibition) | [24] |
Diltiazem (full inhibition) | ||||||
Nifedipine (no effect) | ||||||
 | Microscopy/Fura-2AM | Synthetic peptide ligand of NCAM ectodomain, 50 μM | PC12-E2 cells | ↑ | Not tested | [22] |
 | Fluorimetry/Quin-2AM | Fab fragments of monoclonal NCAM antibodies (H28), 0.1-0.2 mg/ml | PC12 cells | No effect | Not tested | [24] |
 | Microscopy/Fura-2AM | Polyclonal NCAM antibodies, 0.3-0.5 mg/ml | PC12 cells | ↑ | Not tested | [21] |
 | Microscopy/Fura-2AM | Monoclonal NCAM antibodies, 0.1 mg/ml | PC12 cells | No effect | Not tested | [21] |
 | Microscopy/Fura-2AM | NCAM antibodies, 0.5 mg/ml | Chick ciliary ganglion neurons | No effect | Not tested | [39] |
 | Microscopy/Fura-2AM | Polyclonal NCAM antibodies, 0.3-1 mg/ml | Mouse dorsal root ganglion neurons | ↑ | Not tested | [21] |
 | Microscopy/Fura-2AM | Monoclonal NCAM antibodies, 0.1 mg/ml | Mouse dorsal root ganglion neurons | No effect | Not tested | [21] |
 | Microscopy/Fura-2AM | Polyclonal NCAM antibodies, 0.5 mg/ml | Mouse small cerebellar neurons | No effect | Not tested | [21] |
 | Microscopy/Fura-2AM | Monoclonal NCAM antibodies, 0.1 mg/ml | Mouse small cerebellar neurons | No effect | Not tested | [21] |
 | Microscopy/Fura-2AM | Purified NCAM from mouse brain, 10 μg/ml | Mouse small cerebellar neurons | ↑ | Not tested | |
 | Microscopy/Fura-2AM | Recombinant fragments of NCAM ectodomain, 0.8 μM | Mouse small cerebellar neurons | ↑ | Not tested | [25] |
 | Microscopy/Fura-2AM | Monoclonal NCAM antibodies, 30 μg/ml | Mouse cortical neurons (soma) | No effect | Not tested | |
 | Microscopy/Fura-2AM | Synthetic peptide ligand of ectodomain NCAM, 54 μM | Rat hippocampal neurons | ↑ | Not tested | [22] |
 |  | Polyclonal NCAM antibodies, 1 mg/ml | Rat hippocampal neurons | ↑ | Not tested | [22] |
 | Microscopy/ Fura-2AM or Fluo-4AM | Synthetic peptide ligand of NCAM, 12–35 μM | Rat hippocampal neurons (soma) | ↑ | Nifedipine (partial inhibition) | [23] |
Mibefradil (partial inhibition) | ||||||
Pimozide (full inhibition) | ||||||
ω-conotoxin (no inhibition) | ||||||
Agatoxin (no inhibition) | ||||||
Loe908 (partial inhibition) | ||||||
SKF-96365 (partial inhibition) | ||||||
L1 | Fluorimetry/Quin-2AM | Polyclonal L1 antibodies, 0.4-1 mg/ml | PC12 cells | ↑ | Not tested | |
 | Microscopy/Fura-2AM | Polyclonal L1 antibodies, 0.3-1 mg/ml | Mouse dorsal root ganglion neurons | ↑ | Verapamil (no effect) | [21] |
Diltiazem (no effect) | ||||||
Cd2+/Ni2+ (no effect) | ||||||
 | Microscopy/Fura-2AM | Recombinant ectodomain of L1 (L1-Fc), 10 μg/ml | Rat dorsal root ganglion neurons (growth cones) | ↑ a | Nifedipine (full inhibition)a | [37] |
Conotoxin (partial inhibition)a | ||||||
 | Microscopy/Fura-2 dextran | L1 expressed by 3 T3 cells | Rat dorsal root ganglion neurons (growth cones) | No effect | Not tested | [31] |
 | Whole cell patch-clamp | Monoclonal L1 antibodies recognizing glycosylated L1, 7.5-30 μg/ml | Mouse dorsal root ganglion neurons | ↑ | Nifedipine (full inhibition) | [30] |
Cd2+ (full inhibition) | ||||||
 | Microscopy/Fura-2 AM | Polyclonal L1 antibodies, 0.3-0.5 mg/ml | Mouse small cerebellar neurons | ↑ | Verapamil (no effect) | [21] |
Diltiazem (no effect) | ||||||
Cd2+/Ni2+ (No effect) | ||||||
 | Fluorimetry/Quin-2AM; Microscopy/Fura2AM | Purified L1 from mouse brain, 10 μg/ml or 0.8 μM | Mouse small cerebellar neurons | ↑ | Not tested | |
 | Fluorimetry/Quin-2AM | Monoclonal L1 antibodies recognizing FNIII type repeats, 100 μg/ml | Mouse small cerebellar neurons | ↑ | Not tested | [28] |
 | Fluorimetry/Quin-2AM | Monoclonal L1 antibodies recognizing Ig-like domains I-VI, 100 μg/ml | Mouse small cerebellar neurons | No effect | Not tested | |
 | Microscopy/Fura-2AM, | Monoclonal L1 antibodies recognizing glycosylated L1, 7.5-30 μg/ml | Mouse cortical neurons (soma) | ↑ | Nifedipine (full inhibition) | |
Whole cell patch-clamp | ||||||
Cd2+ (full inhibition) | ||||||
Np55 | Microscopy/Fluo-4AM | Soluble recombinant ectodomain of Np55, 15 μM | Rat hippocampal neurons | ↑ | Not tested | [35] |
(synaptic areas) | ||||||
Np65 | Micriscopy/Fluo-4AM | Soluble recombinant ectodomain of Np65, 15 μM | Rat hippocampal neurons | ↑ | Not tested | [34] |
(synaptic areas) | ||||||
 | Micriscopy/Fluo-4AM | Syntetic peptide ligand of Np65 enplastin, 7–15 μM | Rat hippocampal neurons | ↑ | Not tested | [34] |
(synaptic areas) | ||||||
NgCAM | Microscopy/Fluo-3AM; Fura-2AM | Purified chicken NgCAM, 1.2 μg/ml | Neostriatal subependymal zone neurons of adult zebra finch | ↑ | Nifedipine (full inhibition) | [32] |
ω-conotoxin (partial inhibition) | ||||||
 | Microscopy/Fluo-3AM; Fura-2AM | Polyclonal NgCAM antibodies, 100 μg/ml | Neostriatal subependymal zone neurons of adult zebra finch | ↑ | Nifedipine (full inhibition) | [32] |
ω-conotoxin (partial inhibition) | ||||||
LAMP | Microscopy/Fluo-3AM | Soluble recombinant LAMP, 30 μg/ml | Rat hippocampal neuron | ↑ | Nifedipine (full inhibition) | [36] |
ω-conotoxin (no inhibition) | ||||||
 | Microscopy/Fluo-3AM | Soluble recombinant LAMP, 30 μg/ml | Visual cortex neurons | ↑ | Not tested | [36] |
Thy-1 | Microscopy /Fura-2AM | Fab fragments of monoclonal Thy-1 antibodies, 10 μg/ml | PC12 cells (cytosol) | No effect | Not tested | [68] |
Cadherins | Â | Â | Â | Â | Â | Â |
N-cadherin | Microscopy/Fura-2AM | Soluble fragments of N-cadherin purified from brain or retina, 10 μg/ml | Chick ciliary ganglion neurons | ↑ | Mixture of diltiazem and ω-conotoxin (no inhibition) | [39] |
(soma, growth cones) | ||||||
 | Whole cell voltage clamp | Recombinant ectodomain of N-cadherin (N-cadherin-Fc), 20 μg/ml | Chick ciliary ganglion neurons | ↑ | Not tested | [41] |
 | Microscopy/Fura-2AM | Soluble recombinant ectodomain of N-cadherin (N-cadherin-Fc), 50 μg/ml | Chick retinal ganglion cells | No effect | Not tested | [40] |
 | Microscopy/FFP-18-AM | Soluble recombinant ectodomain of N-cadherin (N-cadherin-Fc), 50 μg/ml | Chick retinal ganglion cells (subplasma membrane of growth cones) | ↑ | Mixture of nifedipine and ω-conotoxin (partial inhibition) | [40] |
Celsr2/Celsr3 | Microscopy/Fura-2AM | Soluble recombinant cadherin repeats of Celsr2/Celsr3, 1 μg/ml | Rat hippocampal neurons | ↑ | Not tested | [38] |
Integrins | Â | Â | Â | Â | Â | Â |
β Integrin | Microscopy/Fura-2AM, whole cell voltage clamp | RGD peptide (cGRGDSPA), 1 μM | L. stagnalis CNS motoneurons | ↑ | Not tested | [48] |
(soma) | ||||||
 | High-speed microscopy/Fluo-4AM | Synthetic RGD peptide (RGDS), 0.5-1 μM | Xenopus spinal neurons (growth cones) | ↑ | Not tested | [44] |
 | Microscopy/Fura-2AM | Soluble Laminin, 20 μg/ml | Chick ciliary ganglion neurons (soma) | ↑ | Mixture of diltiazem and ω-conotoxin (no inhibition) | [39] |
 | Microscopy/Fura-2AM | Laminin, immobilized to the beads, 50 μg/ml | Chick dorsal root ganglion neurons (growth cones) | No effect | Not tested | [43] |
 | Microscopy/Fura-2AM | Soluble laminin, 20 μg/ml | Surgically isolated filopodia from growth cones of chick dorsal root ganglion neurons | ↑ | Not tested | [43] |
 | Microscopy/Fura-2AM | RGD peptide (GRGDSP), 10 μM | Mouse cortical neurons (soma and neurites) | ↑ | Gd3+ (partial inhibition) | [45] |
Nifedipine (partial inhibition) | ||||||
 | Whole cell voltage clamp | Polyclonal α5β1 integrin antibodies, 10 μg/ml | Rat basal forebrain neurons | ↑ | Not tested | [47] |
 | Microscopy/Fura-2AM | Syntetic RGD peptide (GRGDSP), 2.5 mM | Rat cortical neurons | ↑ | Not tested | [46] |